Quantitative retention-activity relationship models for quinolones using biopartitioning micellar chromatography

Biomedical Chromatography

Volumn 22, Issue 1, 2008, Pages 106-114

  Wu, Li Ping ^a   Chen, Yu ^b   Wang, Shu Rong ^c   Chen, Cong ^a   Ye, Li Ming ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Biopartitioning micellar chromatography (BMC); Quantitative retention activity relationship (QRAR); Quinolones

Indexed keywords

CHROMATOGRAPHY; PARAMETER ESTIMATION; PHYSIOLOGICAL MODELS;

BIOLOGICAL PARAMETER; BIOPARTITIONING MICELLAR CHROMATOGRAPHIES; BIOPARTITIONING MICELLAR CHROMATOGRAPHY; PARAMETERS ESTIMATION; PHYSIOLOGICAL CONDITION; QUANTITATIVE RETENTION-ACTIVITY RELATIONSHIP; QUINOLONES; RELATIONSHIP MODEL; RETENTION FACTORS; SIMPLE++;

IONIC STRENGTH;

CIPROFLOXACIN; FLEROXACIN; GATIFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RUFLOXACIN; SPARFLOXACIN;

ACCURACY; ANALYTICAL PARAMETERS; AREA UNDER THE CURVE; ARTICLE; BIOPARTITIONING MICELLAR CHROMATOGRAPHY; CHROMATOGRAPHY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG STRUCTURE; IONIC STRENGTH; LD 50; MATHEMATICAL MODEL; PH; PREDICTION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; VALIDITY;

EID: 38749117831     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.907     Document Type: Article

References (25)

1. Balon K, Riebesehl BU and Muller BW. Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption. Pharmaceutical Research 1999; 16: 882-888.
2. Bermúdez-Saldaña JM, Escuder-Gilabert L, Villanueva-Camañas RM, Medina-Hernández MJ and Sagrado S. On the measurement of consistent long-term retention factor values in micellar liquid chromatography. Analytica Chimica Acta 2007; 595: 19-27.
3. Cuenca-Benito M, Sagrado S, Villanueva-Camanas RM and Medina-Hernandez MJ. Quantitative retention-structure and retention-activity relationships of barbiturates by micellar liquid chromatography. Journal of Chromatography A 1998; 814: 121-132.
4. Detroyer A, Vander Heyden Y, Cambre I and Massart DL. Chemometric comparison of recent chromatographic and electrophoretic methods in a quantitative structure-retention and retention-activity relationship context. Journal of Chromatography A 2003; 986: 227-238.
5. Efthimiadou EK, Sanakis Y, Katsaros N, Karaliota A and Psomas G. Transition metal complexes with the quinolone antibacterial agent pipemidic acid: synthesis, characterization and biological activity. Polyhedron 2007; 26: 1148-1158.
6. Escuder-Gilabert L, Sagrado S and Villanueva-Camanas RM. Development of predictive retention-activity relationship models of non-steroidal anti-inflammatory drugs by micellar liquid chromatography: comparison with immobilized artificial membrane columns. Journal of Chromatography B, Biomedical Sciences and Applications 2000; 740: 59-70.
7. Escuder-Gilabert L, Martín-Biosca Y, Sagrado S, Villanueva-Camañas RM and Medina-Hernández MJ. Biopartitioning micellar chromatography to predict ecotoxicity. Analytica Chimica Acta 2001; 448: 173-185.
8. Escuder-Gilabert L, Molero-Monfort M, Villanueva-Camañas RM, Sagrado S and Medina-Hernández MJ. Potential of biopartitioning micellar chromatography as an in vitro technique for predicting drug penetration across the blood-brain barrier. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2004; 807: 193-201.
9. Escuder-Gilabert L, Sagrado S, Vilanueva-Camanas RM and Medina-Hernandez MJ. Quantitative structure-retention relationships for ionic and non-ionic compounds in biopartitioning micellar chromatography. Biomedical Chromatography 2005; 19: 155-168.
10. Gringauz A. Introduction to Medicinal Chemistry. Wiley VCH: New York, 1997.
11. Hilgers AR, Conradi RA and Burton PS. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharmaceutical Research 1990; 7: 902-910.
12. Ma T, Ye LM and Chen Y. The application of quantitative retention-activity relationship models in prediction of oral drug absorption and biological activity. Asian Journal of Drug Metabolish and Pharmacokinetics 2004; 4(4): 251.
13. Molero-Monfort M, Martin-Biosca Y, Sagrado S, Vilianueva-Camanas RM and Medina-Hernandez MJ. Micellar liquid chromatography for prediction of drug transport. Journal of Chromatography A 2000; 870: 1-11.
14. Molero-Monfort M, Escuder-Gilaber L, Villanueva-Camanas RM, Sagrado S and Medina-Hernandez MJ. Biopartitioning micellar chromatography: an in vitro technique for predicting human drug absorption. Journal of Chromatography B, Biomedical Sciences and Applications 2001; 753: 225-236.
15. Outinen K. Optimization of the HPLC; Analysis of biogenic amines in Peucedanum palustre plants and cell culture lines. Planta Medica 1995; 61: 259-263.
16. Quiñones-Torrelo C, Sagrado S, Villanueva-Camañas RM and Medina-Hernández MJ. Development of predictive retention-activity relationship models of tricyclic antidepressants by micellar liquid chromatography. Journal of Medicinal Chemistry 1999; 42: 3154-3162.
17. Quiñones-Torrelo C, Martin-Biosca Y, Martínez-Pla JJ, Sagrado S, Villanueva-Camañas RM and Medina-Hernández MJ. QRAR models for central nervous system drugs using biopartitioning micellar chromatography. Mini Reviews in Medicinal Chemistry 2002; 2: 145-161.
18. Quiñones-Torrelo C, Sagrado S, Villanueva-Camañas RM and Medina-Hernández MS. Role of hydrophobicity on the monoamine receptor binding affinities of central nervous system drugs: a quantitative retention-activity relationships analysis using biopartitioning micellar chromatography. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2004; 801: 185-198.
19. Ritschel WA and Kearns GL. Handbook of Basic Pharmacokinetics: Including Clinical Applications. American Pharmacists Association: Washington, DC, 2004.
20. Sarbu C, Dorina Casoni, Darabantu M and Maiereanu C. Quantitative structure-retention and retention-activity relationships of some 1,3-oxazolidine systems by RP-HPTLC and PCA. Journal of Pharmaceutical and Biomedical Analysis 2004; 35: 213-219.
21. Shargel L, Wu-Pong S and Yu ABC. Applied Biopharmaceuticals and Pharmacokinetics. McGraw-Hill: New York, 2005.
22. Sumin W, Gengliang Y, Hua Z, Haiyan L and Zhiwei L. QRAR models for cardiovascular system drugs using biopartitioning micellar chromatography. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2007; 846: 329-333.
23. The Merck Index. Thirteenth Edition, CD-Rom. Merck & Co. Inc.: New iersey, USA; 2001.
24. Welling PG. Pharmacokinetics of Cardiovascular, Central Nervous System, and Antimicrobial Drugs. The Royal Society of Chemistry: London, 1985.
25. Ye LM, Ma T, Chen C and Chen Y. Study on predictive quantitative retention-activity relationship models of non-steroidal antiinflammatory drugs by micellar liquid chromatography. Chinese Pharmaceutical Journal 2005; 40(22): 61.